Global pharmacovigilance UMC operates the WHO Global Programme for International Drug Monitoring, supports over 180 member countries, and maintains VigiBase. Sales opportunity: offer scalable data governance, secure data exchange, and integration services for pharmacovigilance data across diverse regulatory environments.

Digital solutions The center provides international standards and digital solutions for secure exchange of pharmacovigilance data, including medicine and vaccine terminology. Sales angle: present modernized data schemas, terminology mapping, and API-enabled data sharing platforms to improve interoperability for partners and regulators.

Strategic partnerships Recent collaborations with MedDRA MSSO, CDISC, and Korean MedDRA indicate active ecosystem engagement. Sales leverage: propose co-development or consulting services around standardization, medical terminology alignment, and joint data initiatives to expand reach and adoption.

Non-profit scale UMC is a non-profit foundation with 200 staff and revenue in the low single-digit millions, focused on safer medicine use. Sales angle: offer cost-effective, high-impact health tech solutions, training, and support contracts that align with mission-driven outcomes and grant-funded projects.

Global reach As a WHO-partnered entity supporting 180+ countries, UMC presents a channel for international expansion, capacity-building programs, and regional implementations of pharmacovigilance tools. Sales opportunity: propose global deployment programs, localization services, and long-term support agreements to extend WHO-UMC capabilities.